CDK 7 Inhibitors: Potential in Precision Medicine
CDK 7 inhibitors hold great potential in the field of precision medicine. By targeting specific molecular features of cancer cells and identifying patients most likely to respond, these inhibitors are poised to play a critical role in the future of personalized oncology.